Our study showed a significant reduction of PKA, BDNF and CREB levels following administration of SCOP, which was in line with a previous report that SCOP promoted cognitive deficits in rodents by impairing the CREB–BNDF neurotrophic pathway [42,43]. The gene discussed is CREB1; the disease is Cognitive impairment.